Investigating symptoms and blood test characteristics of acute hepatitis in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize acute hepatitis in pediatric patients by documenting the frequency of various symptoms and analyzing blood test results. It will assess the occurrence of complications associated with acute hepatitis, which can range from mild to severe forms that may lead to liver failure. The study will collect data on patients aged 0 to 17 years who have been diagnosed with acute hepatitis, without interfering with their normal clinical care. By understanding the clinical presentation and laboratory findings, the study seeks to improve recognition and management of this condition in children.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 0 and 17 years (extremes included).
* Access to PSP and/or hospitalized (OBI or hospitalization)
* Diagnosis of acute hepatitis

Exclusion Criteria:

* Refusal of the parent/guardian to participate in the study.
* Mild hypertransaminasemia (\<5 times the upper limit of normal) in a patient with known chronic liver dysfunction (e.g. liver cirrhosis).
* Neonatal jaundice without hepatocyte involvement or signs of cholestasis (prevalence of indirect bilirubin with normal AST, ALT and GGT).

Where it's running

• Azienda USL di Bologna Ospedale Maggiore
  Bologna, Italy Recruiting
• IRCCS Azienda Ospedaliero - Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Study coordinator: Arianna Dondi
• Email: arianna.dondi@aosp.bo.it
• Phone: 0512143012

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ePro Diary for people with HDV (MACROLIVER)

  This project will try a mobile ePro diary app to help adults with Delta hepatitis (HDV) track symptoms and share health information with their care team.

  Recruiting FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · Bergamo, Italy · NCT07442760

• Larsucosterol for people with severe alcohol-associated hepatitis

  This trial will test whether larsucosterol helps people with severe alcohol-associated hepatitis survive 90 days without needing a liver transplant.

  Recruiting at 37 sites Phase 3 Bausch Health Americas, Inc. · Birmingham, Alabama and 91 other locations · NCT07428538

• Comparing two types of ultrasound for patients with viral hepatitis

  This study is testing whether a new ultraportable ultrasound is better than the regular ultrasound for helping patients with viral hepatitis get accurate diagnoses and feel more comfortable during the process.

  Recruiting University of Lausanne Hospitals · Lausanne, Canton of Vaud · NCT06571981

• Low dead-space syringe and needle distribution for people who inject drugs in low- and middle-income countries

  This program will test whether offering low dead-space syringes and needles to people who inject drugs at needle and syringe programs in several low- and middle-income countries increases acceptability and use of safer injecting equipment.

  Recruiting at 9 sites Médecins du Monde · Yerevan and 8 other locations · NCT06395129

• Evaluating HepaCure for treating acute-on-chronic liver failure in Chinese patients

  This study is testing if a new liver support system called HepaCure, used with another treatment, can help Chinese patients with acute-on-chronic liver failure feel better compared to using the other treatment alone.

  Recruiting Phase 1/2 Hexaell Biotech Co., Ltd. · Beijing, Beijing Municipality · NCT05989958

• Evaluating TYNADOTE® for treating acetaminophen overdose

  This study is testing if TYNADOTE® can help people who have overdosed on acetaminophen feel better and recover more effectively when given alongside standard treatment.

  Recruiting Phase 2 Sinew Pharma Inc. · Taipei, Beitou District · NCT05557448

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.